Abbott

Abbott Laboratories is an Illinois corporation whose principal business is discovering, developing, manufacturing and selling a diversified range of healthcare products. Abbott's public history dates to 1888, when a small Chicago pharmacy grew into a global healthcare company; its corporate headquarters are in Abbott Park, Illinois. [1] [2]

For 2025 reporting, Abbott organized its business into four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Medical Devices. The segments cover branded generic medicines sold outside the United States, diagnostic systems and tests, adult and pediatric nutrition, and devices spanning rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care. [1]

The Medical Devices portfolio includes FreeStyle Libre continuous glucose monitoring, CardioMEMS heart-failure monitoring, Aveir leadless pacemakers and structural-heart products such as MitraClip, which Abbott describes as a minimally invasive transcatheter valve-repair therapy. Abbott's 2025 filing reports $7.6 billion in continuous-glucose-monitoring sales, up 17.4% excluding foreign exchange from 2024, while the company's newsroom says the Libre systems were used by about seven million people. [1] [3]

Abbott reports that its products and solutions serve people in more than 160 countries and that it reaches more than two billion people, supported by approximately 122,000 employees worldwide. Taken together, its business combines laboratory diagnostics, nutrition, medicines and medical technologies across both routine care and complex chronic conditions. [2] [1]